🇺🇸 FDA
Patent

US 10940141

Methods for the administration of certain VMAT2 inhibitors

granted A61KA61K31/4375A61K31/4738

Quick answer

US patent 10940141 (Methods for the administration of certain VMAT2 inhibitors) held by Neurocrine Biosciences, Inc. expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/4375, A61K31/4738, A61P, A61P13/12